Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies

This publication has 20 references indexed in Scilit:

• One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies
  Ultrasound in Obstetrics & Gynecology, 2002
• Integrating antenatal Downʼs syndrome screening
  Current Opinion in Obstetrics and Gynecology, 2001
• A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A
  Ultrasound in Obstetrics & Gynecology, 1999
• Maternal age‐ and gestation‐specific risk for trisomy 21
  Ultrasound in Obstetrics & Gynecology, 1999
• UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation
  The Lancet, 1998
• Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free β-hCG and fetal nuchal translucency thickness
  Ultrasound in Obstetrics & Gynecology, 1995
• The imprecision in rates of down syndrome by 1‐year maternal age intervals: A critical analysis of rates used in biochemical screening
  Prenatal Diagnosis, 1994
• Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling
  The Lancet, 1992
• Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
  BMJ, 1992
• RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN
  Published by Elsevier ,1986